NewLink Genetics' Grant

NewLink Genetics raised a round of funding on March 20, 2009. Investors include Qualifying Therapeutic Discovery Project.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.…

Articles about NewLink Genetics' Grant: